A pilot cohort study of deprescribing for nursing home patients acutely admitted to hospital - PubMed (original) (raw)

. 2019 Jun 4:10:2042098619854876.

doi: 10.1177/2042098619854876. eCollection 2019.

Sara Laubscher 2, Gregory W Roberts 2, Arduino A Mangoni 3, Cameron McDonald 4, Ivanka Hendrix 4, Udul Hewage 3, Dirk Hofmann 3, Sophie Michell 2, Lauren Taeuber 2, Richard J Woodman 3, Sepehr Shakib 5, Gregory B Crawford 5, John Maddison 5, Campbell Thompson 5

Affiliations

A pilot cohort study of deprescribing for nursing home patients acutely admitted to hospital

Patrick Russell et al. Ther Adv Drug Saf. 2019.

Abstract

Background: Patients from residential aged care facilities are commonly exposed to inappropriate polypharmacy. Unplanned inpatient admissions can provide an opportunity for review of complex medical regimens and deprescribing of inappropriate or nonbeneficial medications. The aim of this study was to assess the efficacy, safety and sustainability of in-hospital deprescribing.

Methods: We followed a prospective, multi-centre, cohort study design, with enrolment of 106 medical inpatients age 75 years and older (mean age was 88.8 years) who were exposed to polypharmacy prior to admission and with a planned discharge to a nursing home for permanent placement. Descriptive statistics were calculated for relevant variables. The Short Form-8 (SF-8) health survey was used to assess changes in health-related quality of life (HRQOL) at 90-day follow up, in comparison with SF-8 results at day 30.

Results: Deprescribing occurred in most, but not all patients. There were no differences between the groups in principal diagnosis, Charlson index, number of medications on admission or number of Beers list medications on admission. At 90 days, mortality and readmissions were similar, though the deprescribed group had significantly higher odds of better emotional wellbeing than the nondeprescribed group [odds ratio (OR) = 5.08, 95% confidence interval (CI): 1.93, 13.39; p = 0.001]. In the deprescribing group, 31% of the patients still alive at 90 days had medications restarted in primary care. One-year mortality rates were similar.

Conclusions: Deprescribing medications during an unplanned hospital admission was not associated with mortality, readmissions, or overall HRQOL.

Keywords: deprescribing; health-related quality of life; hospital medicine; mortality; nursing homes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Similar articles

Cited by

References

    1. Lane H, Zordan RD, Weiland TJ, et al. Hospitalisation of high-care residents of aged care facilities: are goals of care discussed? Intern Med J 2013; 43: 144–149. - PubMed
    1. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205. - PubMed
    1. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015; 175: 827–834. - PubMed
    1. Reeve E, To J, Hendrix I, Shakib S, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013; 30: 793–807. - PubMed
    1. Palagyi A, Keay L, Harper J, et al. Barricades and brickwalls: a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr 2016; 15-1– 15-11. - PMC - PubMed

LinkOut - more resources